Mechanisms of angiogenesis and arteriogenesis

Nature Medicine

Volumn 6, Issue 4, 2000, Pages 389-395

  Carmeliet, Peter ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; PROTEINASE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; GENE TARGETING; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIOLES; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0034076189     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/74651     Document Type: Review

References (71)

1. Risau, W. Mechanisms of angiogenesis. Nature 386, 671 -674 (1997).
2. Benjamin, L.E., Hemo, I. & Keshet, E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF- B and VEGF. Development 125, 1591-1598 (1998).
3. Hirschi, K.K. & d'Amore, P.A. Pericytes in the microvasculature. Cardiovasc. Res. 32, 687-698 (1996).
4. Ferrara, N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56, 794-814 (1999).
5. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single vascular endothelial growth factor allele. Nature 380, 435-439 (1996).
6. Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442 (1996).
7. Shalaby, F., Ho, J., Stanford, W.L. & al, e. A requirement for Flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89, 981-990 (1997).
8. Fong, G.H., Zhang, L., Bryce, D.M. & Peng, J. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 126, 3015-3025 (1999).
9. Dickson, M.C. et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121, 1845-1854 (1995).
10. Bader, B.L., Rayburn, H., Crowley, D. & Hynes, R.O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 95, 507-519 (1998).
11. Lyden, D. et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670-677 (1999).
12. Carmeliet, P. Developmental biology. Controlling the cellular brakes [news]. Nature 401, 657-658 (1999).
13. Zhong, T.P., Rosenberg, M., Mohideen, M.A., Weinstein, B. & Fishman, M.C. grid-lock, an HLH Gene Required for Assembly of the Aorta in Zebrafish. Science 287, 1820-1824 (2000).
14. Gale, N.W. & Yancopoulos, G.D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13, 1055-1066 (1999).
15. Takahashi, T. et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5, 434-438 (1999).
16. Peichev, M. et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood-95(2000).
17. Eliceiri, B.P. et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4, 915-924 (1999).
18. Thurston, G. et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nature Medicine 6, 1-4 (2000).
19. Maisonpierre, P.C. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60 (1997).
20. Coussens, L.M. et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13, 1382-1397 (1999).
21. Heymans, S. et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure [In Process Citation]. Nat Med 5, 1135-1142 (1999).
22. Vu, T.H. et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422 (1998).
23. Bajou, K. et al. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4, 923-928 (1998).
24. Brooks, P.C., Silletti, S., von Schalscha, T.L., Friedlander, M. & Cheresh, D.A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92, 391-400 (1998).
25. Taipale, J. et al. Vascular endothelial growth factor receptor-3. Curr Top Microbiol Immunol 237, 85-96 (1999).
26. Soker, S., Takashima, S., Miao, H.Q., Neufeld, G. & Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745 (1998).
27. Gerber, H.P. et al. VEGF is required for growth and survival in neonatal mice. Development 126, 1149-1159 (1999).
28. Carmeliet, P. et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 5, 495-502 (1999).
29. Dumont, D.J. et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282, 946-949 (1998).
30. Ferrara, N. & Alitalo, K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5, 1359-1364 (1999).
31. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T. & Shibuya, M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci U S A 95, 9349-9354 (1998).
32. Suri, C. et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 282, 468-471 (1998).
33. Zhou, M. et al. Fibroblast growth factor 2 control of vascular tone. Nat Med 4, 201-207 (1998).
34. Lindahl, P., Hellstrom, M., Kalen, M. & Betsholtz, C. Endothelial-perivascular cell signaling in vascular development: lessons from knockout mice. Curr Opin Lipidol 9, 407-411 (1998).
35. Gohongi, T. et al. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1. Nat Med 5, 1203-1208 (1999).
36. Varner, J.A., Brooks, P.C. & Cheresh, D.A. Review: The integrin αvβ3: angiogenesis and apoptosis. Cell Adhesion Communication 3, 367-374 (1995).
37. Murohara, T. et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101, 2567-2578 (1998).
38. O'Reilly, M.S. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppresion of metastases by a Lewis lung carcinoma. Cell 79, 315-328 (1994).
39. O'Reilly, M.S. et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285 (1997).
40. Helmlinger, G., Yuan, F., Dellian, M. & Jain, R.K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 3, 177-182 (1997).
41. Carmeliet, P. et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98, 147-157 (1999).
42. Jain, R.K. et al. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc Natl Acad Sci U S A 95, 10820-10825 (1998).
43. Alon, T. et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1, 1024-1028 (1995).
44. Holash, J., Wiegand, S.J. & Yancopoulos, G.D. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18, 5356-5362 (1999).
45. Risau, W. Development and differentiation of endothelium. Kidney Int Suppl 67, S3-6 (1998).
46. Maniotis, A.J. et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155, 739-752 (1999).
47. Ellerby, H.M. et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 5, 1032-1038 (1999).
48. Patan, S. TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. Microvasc Res 56, 1-21 (1998).
49. Dettman, R.W., Denetclaw, W., Jr., Ordahl, C.P. & Bristow, J. Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev Biol 193, 169-181 (1998).
50. Creazzo, T.L., Godt, R.E., Leatherbury, L., Conway, S.J. & Kirby, M.L. Role of cardiac neural crest cells in cardiovascular development. Annu Rev Physiol 60, 267-286 (1998).
51. Suri, C. et al. Requisite role of angiopotetin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180 (1996).
52. Li, D.Y. et al. Defective angiogenesis in mice lacking endoglin. Science 284, 1534-1537 (1999).
53. Yanagisawa, H. et al. Role of Endothelin-1/Endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice. J Clin Invest 102, 22-33 (1998).
54. Lin, Q. et al. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125, 4565-4574 (1998).
55. Reddi, V., Zaglul, A., Pentz, E.S. & Gomez, R.A. Renin-expressing cells are associated with branching of the developing kidney vasculature. J Am Soc Nephrol 9, 63-71 (1998).
56. Schaper, W. & Ito, W.D. Molecular mechanisms of coronary collateral vessel growth. Circ Res 79, 911-919 (1996).
57. Pereira, L. et al. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nature Genetics 17, 218-222 (1997).
58. Li, D.Y. et al. Elastin is an essential determinant of arterial morphogenesis. Nature 393, 276-280 (1998).
59. Segi, E. et al. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun 246, 7-12 (1998).
60. Gourdie, R.G., Wei, Y., Kim, D., Klatt, S.C. & Mikawa, T. Endothelin-induced conversion of embryonic heart muscle cells into impulse-conducting Purkinje fibers. Proc Natl Acad Sci U S A 95, 6815-6818 (1998).
61. Kawasaki, T. et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 126, 4895-4902 (1999).
62. Semenza, G.L. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 8, 588-594 (1998).
63. Maltepe, E., Schmidt, J.V., Baunoch, D., Bradfield, C.A. & Simon, C.M. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386, 403-407 (1997).
64. Carmeliet, P. et al. Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485-490 (1998).
65. Li, J. et al. PR39, a peptide regulator of angiogenesis. Nat Med 6, 49-55 (2000).
66. Vrancken Peeters, M.P. et al. Differences in development of coronary arteries and veins. Cardiovasc Res 36, 101-110 (1997).
67. Jeltsch, M. et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423-1425 (1997).
68. Wigle, J.T. & Oliver, G. Prox1 function is required for the development of the murine lymphatic system. Cell 98, 769-778 (1999).
69. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R. & Sorg, C. Macrophages and angiogenesis. J Leukoc Biol 55, 410-422 (1994).
70. Isner, J. VEGF and neuropathy. Nature Medicine 6, 405-413 (2000): please, complete; I don't have the-full reference yet.
71. Thurston, G., Murphy, T.J., Baluk, P., Lindsey, J.R. & McDonald, D.M. Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am J Pathol 153, 1099-1112 (1998).